Filing Details
- Accession Number:
- 0001325812-13-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 19:04:05
- Reporting Period:
- 2013-12-16
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 19:04:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458494 | Akshay Vaishnaw | 300 Third Street Cambridge MA 02139 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-16 | 3,750 | $9.14 | 16,338 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-12-16 | 6,250 | $9.30 | 22,588 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-12-16 | 5,000 | $7.10 | 27,588 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-16 | 10,744 | $60.19 | 16,844 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-16 | 4,256 | $60.78 | 12,588 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-12-17 | 18,480 | $12.96 | 31,068 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-17 | 8,500 | $60.59 | 22,568 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-17 | 9,980 | $61.40 | 12,588 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 5,000 | $0.00 | 5,000 | $7.10 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 3,750 | $0.00 | 3,750 | $9.14 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-16 | 6,250 | $0.00 | 6,250 | $9.30 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-17 | 18,480 | $0.00 | 18,480 | $12.96 |
Common Stock | Stock Option (right to buy) | Acquisiton | 2013-12-18 | 32,500 | $0.00 | 32,500 | $63.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2021-11-30 | No | 4 | M | Direct | |
7,500 | 2020-12-08 | No | 4 | M | Direct | |
37,500 | 2021-06-09 | No | 4 | M | Direct | |
22,145 | 2016-01-02 | No | 4 | M | Direct | |
32,500 | 2023-12-18 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,615 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan.
- Sale prices ranged from $59.61 to $60.54.
- Sale prices ranged from $60.62 to $61.29.
- Sale prices ranged from $59.99 to $60.98.
- Sale prices ranged from $60.99 to $61.96.
- The reporting person owns 2,615 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.